| First Author | Laplante M | Year | 2012 |
| Journal | Cell | Volume | 149 |
| Issue | 2 | Pages | 274-93 |
| PubMed ID | 22500797 | Mgi Jnum | J:319697 |
| Mgi Id | MGI:6840119 | Doi | 10.1016/j.cell.2012.03.017 |
| Citation | Laplante M, et al. (2012) mTOR signaling in growth control and disease. Cell 149(2):274-93 |
| abstractText | The mechanistic target of rapamycin (mTOR) signaling pathway senses and integrates a variety of environmental cues to regulate organismal growth and homeostasis. The pathway regulates many major cellular processes and is implicated in an increasing number of pathological conditions, including cancer, obesity, type 2 diabetes, and neurodegeneration. Here, we review recent advances in our understanding of the mTOR pathway and its role in health, disease, and aging. We further discuss pharmacological approaches to treat human pathologies linked to mTOR deregulation. |
